The HLA-E protein is frequently overexpressed GBM in vivo and in vitro, and its presence in GBM tumor cells has been shown to impair NK cytotoxicity in an NKG2A/CD94-dependent manner [148]. The gene discussed is HLA-E; the disease is glioblastoma.